cardiologist doctor physician patient black diverse hypertension

U.S. News and World Report reviewed 660 hospitals, ranking them based on data related to treating diabetes and endocrinology. 

Newsweek ranked the 50 best heart hospitals in the world

Leadless pacemakers may be an "attractive alternative" to transvenous devices when cardiologists treat older TAVR patients who experience conduction disorders.

HeartFlow introduced its next generation artificial intelligence (AI) Plaque Analysis with an interactive experience at SCCT 2024. It shows a 3D plaque model and analysis by territory across calcified, non-calcified and low-attenuation plaques. This includes viewing cross-sectional, color-coded images of each plaque type where it was quantified along the vessel. #SCCT #SCCT24 #SCCT2024

HeartFlow is using SCCT 2024 to introduce the world to its updated Plaque Analysis platform. “Accurately diagnosing a patient’s risk for coronary artery disease is critical for determining the best treatment," Chief Medical Officer Campbell Rogers, MD, explained.

Cordis has received U.S. Food and Drug Administration (FDA) approval for its new MYNX Control Venous Vascular Closure Device (VCD) for 6F-12F access sites. The company hopes to launch the newly approved extravascular closure device in the months ahead.

The newly approved extravascular closure device was designed for procedures with access sites from 6 to 12 French. It uses the same proprietary GRIP technology found in other Cordis interventional devices.

Around the web

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."